These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35661930)
1. HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression. Xiang L; Wang Y; Lan J; Na F; Wu S; Gong Y; Du H; Shao B; Xie G Cell Mol Life Sci; 2022 Jun; 79(6):343. PubMed ID: 35661930 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer. Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814 [TBL] [Abstract][Full Text] [Related]
3. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3. Ahmmed B; Kampo S; Khan M; Faqeer A; Kumar SP; Yulin L; Liu JW; Yan Q J Cell Physiol; 2019 Jul; 234(7):10680-10697. PubMed ID: 30628067 [TBL] [Abstract][Full Text] [Related]
4. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer. Yang N; Liang Y; Yang P; Ji F Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124 [TBL] [Abstract][Full Text] [Related]
5. Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α. Biziotis OD; Tsakiridis EE; Ali A; Ahmadi E; Wu J; Wang S; Mekhaeil B; Singh K; Menjolian G; Farrell T; Abdulkarim B; Sur RK; Mesci A; Ellis P; Berg T; Bramson JL; Muti P; Steinberg GR; Tsakiridis T Mol Oncol; 2023 Nov; 17(11):2235-2256. PubMed ID: 37584455 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery. Felip E; Taron M; Rosell R; Mendez P; Queralt C; Ronco MS; Sanchez JJ; Sanchez JM; Maestre J; Majo J Clin Lung Cancer; 2005 Mar; 6(5):299-303. PubMed ID: 15845181 [TBL] [Abstract][Full Text] [Related]
7. Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer. Chen YQ; Zhao CL; Li W J Exp Clin Cancer Res; 2009 Feb; 28(1):29. PubMed ID: 19245702 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation. Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342 [TBL] [Abstract][Full Text] [Related]
10. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4. Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748 [No Abstract] [Full Text] [Related]
12. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR. Meng S; Wang G; Lu Y; Fan Z Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells. Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110 [TBL] [Abstract][Full Text] [Related]
15. Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation. Kong P; Yu KN; Yang M; Almahi WA; Nie L; Chen G; Han W Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403326 [TBL] [Abstract][Full Text] [Related]
16. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α. Gao H; Xie J; Peng J; Han Y; Jiang Q; Han M; Wang C Exp Cell Res; 2015 Mar; 332(2):236-46. PubMed ID: 25499970 [TBL] [Abstract][Full Text] [Related]
17. FV-429 enhances the efficacy of paclitaxel in NSCLC by reprogramming HIF-1α-modulated FattyAcid metabolism. Guo Y; Yang L; Guo W; Wei L; Zhou Y Chem Biol Interact; 2021 Dec; 350():109702. PubMed ID: 34648812 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells. Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. He X; Wang J; Wei W; Shi M; Xin B; Zhang T; Shen X Cancer Biol Ther; 2016; 17(2):188-98. PubMed ID: 26785721 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1α expression in human non-small cell lung cancer cells. Guo L; Li L; Wang W; Pan Z; Zhou Q; Wu Z Biochim Biophys Acta; 2012 Jun; 1822(6):852-61. PubMed ID: 22349311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]